Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and Treatment
Clinical trial NCT02614898 · TERMINATED
Trial details
- NCT number
- NCT02614898
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-04
- Primary completion
- 2017-10-05
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.